Skip to content
Prototype · Illustrative synthetic data · Not real patient or company data

Access & Coverage

Level 2 · Market Access

Launch phaseView as
Synthetic snapshot Launch Week 14 · Claims held W13
Viewing as Brand lead · Level 1 · Governance read-only

Payer and account strategy: where prior authorization is fast, where it stalls, and why.

-1pt
86%
Coverage approval rate
vs W13
Certified KPI
+3d
18days
Median time to coverage
vs W13
Certified KPI
+5pt
80%
Appeal overturn rate
2 pending · vs W13
Certified KPI
+3
43
PAs submitted (cum.)
vs W13
Certified KPI

PA approval rate trend

% approved of final adjudicated · W1–W14

Payer mix

% of hub-enrolled patients

46
enrolled
Commercial42%
Medicare32%
Medicaid18%
Other8%

Time-to-coverage distribution

Approved patients by days hub → coverage

Commercial15d median
Medicare17d median
Medicaid26d median
Other19d median

Top denial reasons

Initial denials to date

Appeals outcomes

7 appeals filed

Overturned4
Pending2
Upheld1

Most overturns followed resubmission with the FUS genetic report attached — the strongest lever for reducing time to coverage.